Lexington, Mass. — (BUSINESS WIRE) — July 29, 2015 — Imprivata® (NYSE: IMPR), a leading provider of IT security and identity solutions to the healthcare industry, today announced financial results for three and six months ended June 30, 2015. Revenues for the three months ended June 30, 2015 were $30.0 million, an increase of 29% from revenues of $23.2 million for the same period in 2014. Revenues for the six months ended June 30, 2015 were $55.6 million, an increase of 30% from revenues of $42.7 million for the same period in 2014.
While most other industries have enjoyed a decades-long marriage with the Internet, in health care, we’re still in the “getting to know you” phase, working to establish a level of trust. Understandably, there are major concerns in our industry surrounding data integrity, both in and outside of the firewall.
Thieves use stolen personal data to get treatment, drugs, and medical equipment. An estimated 2.3 million adults were affected by medical identity theft last year. Some hospitals are turning to new technology such as biometric screening to confirm patient identities.
Cambridge Health Alliance will be among the first big hospital operators in the state to roll out new technology that allows doctors to electronically send prescriptions for controlled substances directly to pharmacies. Hospital officials say next month’s small but important software upgrade will improve monitoring of prescriptions and reduce fraud and counterfeiting.
CHA is the First Healthcare Organization in Massachusetts to Deploy Imprivata Confirm ID with Hands Free Authentication to Help Meet DEA Requirements for EPCS and Reduce Drug Diversion and Fraud
As an infrastructure security network systems integrator, we offer to accompany our customers on audit phases, consulting, integration, skills transfer and support.
We have distributed and integrated the Imprivata SSO solution since 2008 in the hospital environment as well as in the government and private sector.